Global Alternative to Antibiotics Market Research Report 2025
- Published Date: 2024-12-18
- Report ID: 9165699
- Pages: 200
-
Format:
Report Overview
This report provides a deep insight into the global Alternative to Antibiotics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Alternative to Antibiotics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Alternative to Antibiotics market in any manner.
Global Alternative to Antibiotics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
DSM
DuPont(Danisco)
Chr. Hansen
Lallemand
China-Biotics
Nestle
Danone
Probi
BioGaia
Yakult
Novozymes
Valio
Glory Biotech
Ganeden
Morinaga Milk Industry
Sabinsa
Greentech
Bioriginal
Biosearch Life
UAS Laboratories
Synbiotech
Market Segmentation (by Type)
Antimicrobial Proteins
Bacteriophages
Probiotics
Other
Market Segmentation (by Application)
Food & Beverage
Drugs
Dietary Supplements
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Alternative to Antibiotics Market
Overview of the regional outlook of the Alternative to Antibiotics Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porters five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Alternative to Antibiotics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Alternative to Antibiotics
1.2 Key Market Segments
1.2.1 Alternative to Antibiotics Segment by Type
1.2.2 Alternative to Antibiotics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Alternative to Antibiotics Market Overview
2.1 Global Market Overview
2.1.1 Global Alternative to Antibiotics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Alternative to Antibiotics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Alternative to Antibiotics Market Competitive Landscape
3.1 Global Alternative to Antibiotics Sales by Manufacturers (2019-2024)
3.2 Global Alternative to Antibiotics Revenue Market Share by Manufacturers (2019-2024)
3.3 Alternative to Antibiotics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Alternative to Antibiotics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Alternative to Antibiotics Sales Sites, Area Served, Product Type
3.6 Alternative to Antibiotics Market Competitive Situation and Trends
3.6.1 Alternative to Antibiotics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Alternative to Antibiotics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Alternative to Antibiotics Industry Chain Analysis
4.1 Alternative to Antibiotics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Alternative to Antibiotics Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Alternative to Antibiotics Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Alternative to Antibiotics Sales Market Share by Type (2019-2024)
6.3 Global Alternative to Antibiotics Market Size Market Share by Type (2019-2024)
6.4 Global Alternative to Antibiotics Price by Type (2019-2024)
7 Alternative to Antibiotics Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Alternative to Antibiotics Market Sales by Application (2019-2024)
7.3 Global Alternative to Antibiotics Market Size (M USD) by Application (2019-2024)
7.4 Global Alternative to Antibiotics Sales Growth Rate by Application (2019-2024)
8 Alternative to Antibiotics Market Segmentation by Region
8.1 Global Alternative to Antibiotics Sales by Region
8.1.1 Global Alternative to Antibiotics Sales by Region
8.1.2 Global Alternative to Antibiotics Sales Market Share by Region
8.2 North America
8.2.1 North America Alternative to Antibiotics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Alternative to Antibiotics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Alternative to Antibiotics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Alternative to Antibiotics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Alternative to Antibiotics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 DSM
9.1.1 DSM Alternative to Antibiotics Basic Information
9.1.2 DSM Alternative to Antibiotics Product Overview
9.1.3 DSM Alternative to Antibiotics Product Market Performance
9.1.4 DSM Business Overview
9.1.5 DSM Alternative to Antibiotics SWOT Analysis
9.1.6 DSM Recent Developments
9.2 DuPont(Danisco)
9.2.1 DuPont(Danisco) Alternative to Antibiotics Basic Information
9.2.2 DuPont(Danisco) Alternative to Antibiotics Product Overview
9.2.3 DuPont(Danisco) Alternative to Antibiotics Product Market Performance
9.2.4 DuPont(Danisco) Business Overview
9.2.5 DuPont(Danisco) Alternative to Antibiotics SWOT Analysis
9.2.6 DuPont(Danisco) Recent Developments
9.3 Chr. Hansen
9.3.1 Chr. Hansen Alternative to Antibiotics Basic Information
9.3.2 Chr. Hansen Alternative to Antibiotics Product Overview
9.3.3 Chr. Hansen Alternative to Antibiotics Product Market Performance
9.3.4 Chr. Hansen Alternative to Antibiotics SWOT Analysis
9.3.5 Chr. Hansen Business Overview
9.3.6 Chr. Hansen Recent Developments
9.4 Lallemand
9.4.1 Lallemand Alternative to Antibiotics Basic Information
9.4.2 Lallemand Alternative to Antibiotics Product Overview
9.4.3 Lallemand Alternative to Antibiotics Product Market Performance
9.4.4 Lallemand Business Overview
9.4.5 Lallemand Recent Developments
9.5 China-Biotics
9.5.1 China-Biotics Alternative to Antibiotics Basic Information
9.5.2 China-Biotics Alternative to Antibiotics Product Overview
9.5.3 China-Biotics Alternative to Antibiotics Product Market Performance
9.5.4 China-Biotics Business Overview
9.5.5 China-Biotics Recent Developments
9.6 Nestle
9.6.1 Nestle Alternative to Antibiotics Basic Information
9.6.2 Nestle Alternative to Antibiotics Product Overview
9.6.3 Nestle Alternative to Antibiotics Product Market Performance
9.6.4 Nestle Business Overview
9.6.5 Nestle Recent Developments
9.7 Danone
9.7.1 Danone Alternative to Antibiotics Basic Information
9.7.2 Danone Alternative to Antibiotics Product Overview
9.7.3 Danone Alternative to Antibiotics Product Market Performance
9.7.4 Danone Business Overview
9.7.5 Danone Recent Developments
9.8 Probi
9.8.1 Probi Alternative to Antibiotics Basic Information
9.8.2 Probi Alternative to Antibiotics Product Overview
9.8.3 Probi Alternative to Antibiotics Product Market Performance
9.8.4 Probi Business Overview
9.8.5 Probi Recent Developments
9.9 BioGaia
9.9.1 BioGaia Alternative to Antibiotics Basic Information
9.9.2 BioGaia Alternative to Antibiotics Product Overview
9.9.3 BioGaia Alternative to Antibiotics Product Market Performance
9.9.4 BioGaia Business Overview
9.9.5 BioGaia Recent Developments
9.10 Yakult
9.10.1 Yakult Alternative to Antibiotics Basic Information
9.10.2 Yakult Alternative to Antibiotics Product Overview
9.10.3 Yakult Alternative to Antibiotics Product Market Performance
9.10.4 Yakult Business Overview
9.10.5 Yakult Recent Developments
9.11 Novozymes
9.11.1 Novozymes Alternative to Antibiotics Basic Information
9.11.2 Novozymes Alternative to Antibiotics Product Overview
9.11.3 Novozymes Alternative to Antibiotics Product Market Performance
9.11.4 Novozymes Business Overview
9.11.5 Novozymes Recent Developments
9.12 Valio
9.12.1 Valio Alternative to Antibiotics Basic Information
9.12.2 Valio Alternative to Antibiotics Product Overview
9.12.3 Valio Alternative to Antibiotics Product Market Performance
9.12.4 Valio Business Overview
9.12.5 Valio Recent Developments
9.13 Glory Biotech
9.13.1 Glory Biotech Alternative to Antibiotics Basic Information
9.13.2 Glory Biotech Alternative to Antibiotics Product Overview
9.13.3 Glory Biotech Alternative to Antibiotics Product Market Performance
9.13.4 Glory Biotech Business Overview
9.13.5 Glory Biotech Recent Developments
9.14 Ganeden
9.14.1 Ganeden Alternative to Antibiotics Basic Information
9.14.2 Ganeden Alternative to Antibiotics Product Overview
9.14.3 Ganeden Alternative to Antibiotics Product Market Performance
9.14.4 Ganeden Business Overview
9.14.5 Ganeden Recent Developments
9.15 Morinaga Milk Industry
9.15.1 Morinaga Milk Industry Alternative to Antibiotics Basic Information
9.15.2 Morinaga Milk Industry Alternative to Antibiotics Product Overview
9.15.3 Morinaga Milk Industry Alternative to Antibiotics Product Market Performance
9.15.4 Morinaga Milk Industry Business Overview
9.15.5 Morinaga Milk Industry Recent Developments
9.16 Sabinsa
9.16.1 Sabinsa Alternative to Antibiotics Basic Information
9.16.2 Sabinsa Alternative to Antibiotics Product Overview
9.16.3 Sabinsa Alternative to Antibiotics Product Market Performance
9.16.4 Sabinsa Business Overview
9.16.5 Sabinsa Recent Developments
9.17 Greentech
9.17.1 Greentech Alternative to Antibiotics Basic Information
9.17.2 Greentech Alternative to Antibiotics Product Overview
9.17.3 Greentech Alternative to Antibiotics Product Market Performance
9.17.4 Greentech Business Overview
9.17.5 Greentech Recent Developments
9.18 Bioriginal
9.18.1 Bioriginal Alternative to Antibiotics Basic Information
9.18.2 Bioriginal Alternative to Antibiotics Product Overview
9.18.3 Bioriginal Alternative to Antibiotics Product Market Performance
9.18.4 Bioriginal Business Overview
9.18.5 Bioriginal Recent Developments
9.19 Biosearch Life
9.19.1 Biosearch Life Alternative to Antibiotics Basic Information
9.19.2 Biosearch Life Alternative to Antibiotics Product Overview
9.19.3 Biosearch Life Alternative to Antibiotics Product Market Performance
9.19.4 Biosearch Life Business Overview
9.19.5 Biosearch Life Recent Developments
9.20 UAS Laboratories
9.20.1 UAS Laboratories Alternative to Antibiotics Basic Information
9.20.2 UAS Laboratories Alternative to Antibiotics Product Overview
9.20.3 UAS Laboratories Alternative to Antibiotics Product Market Performance
9.20.4 UAS Laboratories Business Overview
9.20.5 UAS Laboratories Recent Developments
9.21 Synbiotech
9.21.1 Synbiotech Alternative to Antibiotics Basic Information
9.21.2 Synbiotech Alternative to Antibiotics Product Overview
9.21.3 Synbiotech Alternative to Antibiotics Product Market Performance
9.21.4 Synbiotech Business Overview
9.21.5 Synbiotech Recent Developments
10 Alternative to Antibiotics Market Forecast by Region
10.1 Global Alternative to Antibiotics Market Size Forecast
10.2 Global Alternative to Antibiotics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Alternative to Antibiotics Market Size Forecast by Country
10.2.3 Asia Pacific Alternative to Antibiotics Market Size Forecast by Region
10.2.4 South America Alternative to Antibiotics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Alternative to Antibiotics by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Alternative to Antibiotics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Alternative to Antibiotics by Type (2025-2030)
11.1.2 Global Alternative to Antibiotics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Alternative to Antibiotics by Type (2025-2030)
11.2 Global Alternative to Antibiotics Market Forecast by Application (2025-2030)
11.2.1 Global Alternative to Antibiotics Sales (Kilotons) Forecast by Application
11.2.2 Global Alternative to Antibiotics Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
